-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Therapeutics for Thrombosis

PhD Trainee  Ticketed Session
Program: Meet the Scientist
Saturday, December 5, 2015: 11:15 AM-12:15 PM
Bayhill 33 (Hyatt Regency Orlando)
Speaker:
Jeffrey I. Weitz, MD, FRCPC, FACP, Thrombosis & Atherosclerosis Research Institute

Disclosures:
Weitz: Janssen: Consultancy , Honoraria ; Portola: Consultancy , Honoraria ; Pfizer: Consultancy , Honoraria ; Bristol Myers Squibb: Consultancy , Honoraria ; Daiichi Sankyo: Consultancy , Honoraria ; Bayer: Consultancy , Honoraria ; Boehringer Ingelheim: Consultancy , Honoraria ; ISIS Pharmaceuticals: Consultancy , Honoraria .
See more of: Meet the Scientist
<< Previous Session | Next Session >>